These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2154435)

  • 1. In-vitro activity of azithromycin compared with other macrolides and oral antibiotics against Salmonella typhi.
    Metchock B
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():29-31. PubMed ID: 2154435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in antibiotic susceptibility of enteric fever isolates in East London.
    Dave J; Sefton A; de Pinna E; Woodford N; Meade R; Jordan M; Grant K; Holliman R; Millar M
    Travel Med Infect Dis; 2015; 13(3):230-4. PubMed ID: 25964222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of azithromycin (CP-62,993), a novel macrolide, against enteric pathogens.
    Jones K; Felmingham D; Ridgway G
    Drugs Exp Clin Res; 1988; 14(10):613-5. PubMed ID: 2854515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophages.
    Chang HR; Vladoianu IR; Pechère JC
    J Antimicrob Chemother; 1990 Nov; 26(5):689-94. PubMed ID: 2079450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Effect of New Antibiotics Against Clinical Isolates of Salmonella Typhi.
    Malik N; Ahmed M
    J Coll Physicians Surg Pak; 2016 Apr; 26(4):288-92. PubMed ID: 27097699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.
    Maskell JP; Sefton AM; Williams JD
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():19-24. PubMed ID: 2154433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Salmonella activity of CP-99,219, a novel azabicyclo-naphthridone fluoroquinolone.
    Qadri SM; Cunha BA; Ueno Y; Walters EA
    Chemotherapy; 1996; 42(6):439-42. PubMed ID: 8957578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative activity of azithromycin against 100 strains of Neisseria gonorrhoeae].
    Chevalier B; Crenn Y; Cavallo JD; Plotton N; Meyran M
    Pathol Biol (Paris); 1995 Apr; 43(4):281-3. PubMed ID: 7567115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale of azithromycin prescribing practices for enteric fever in India.
    Rai S; Jain S; Prasad KN; Ghoshal U; Dhole TN
    Indian J Med Microbiol; 2012; 30(1):30-3. PubMed ID: 22361757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
    Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
    Cent Eur J Public Health; 2017 Dec; 25(4):282-286. PubMed ID: 29346850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surveillance of antimicrobial susceptibility of Haemophilus influenzae isolates from children in Beijing, Shanghai, and Guangzhou 2000 - 2002].
    Shen XZ; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Jiang M; Hu YY; Yang YH
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1335-9. PubMed ID: 15387940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibility of Campylobacter jejuni clinical isolates from children to eight antibiotics].
    García-Campos JA; Alarcón T; Domingo D; Menéndez-Rivas M; López-Brea M
    Rev Esp Quimioter; 2003 Jun; 16(2):216-20. PubMed ID: 12973460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised ciprofloxacin breakpoints for Salmonella Typhi: its implications in India.
    Balaji V; Sharma A; Ranjan P; Kapil A
    Indian J Med Microbiol; 2014; 32(2):161-3. PubMed ID: 24713903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
    Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis.
    Slaney L; Chubb H; Ronald A; Brunham R
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():1-5. PubMed ID: 2154426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
    Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
    J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outbreak of multiresistant Salmonella typhi in South Africa.
    Coovadia YM; Gathiram V; Bhamjee A; Garratt RM; Mlisana K; Pillay N; Madlalose T; Short M
    Q J Med; 1992 Feb; 82(298):91-100. PubMed ID: 1620817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of azithromycin against bacterial enteric pathogens.
    Gordillo ME; Singh KV; Murray BE
    Antimicrob Agents Chemother; 1993 May; 37(5):1203-5. PubMed ID: 8390813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.